Clinical Approach to Ascites
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of ascites
Ascites represents one of the most common complications of chronic liver disease, affecting approximately 50% of patients with cirrhosis within 10 years of diagnosis. It is the leading cause of hospital admission among patients with cirrhosis and signals a significant decline in prognosis, with 1-year mortality rates of approximately 15% for uncomplicated ascites and up to 40% for refractory ascites. Beyond hepatic causes, ascites accounts for significant morbidity in malignancy, heart failure, and other conditions, making it a critical presentation for clinicians across multiple specialties to recognize and manage appropriately.
Definition
Ascites is the pathological accumulation of fluid within the peritoneal cavity. The term derives from the Greek word “askos” meaning bag or sac. Normally, the peritoneal cavity contains less than 50 milliliters of serous fluid that facilitates frictionless movement of abdominal organs. Ascites becomes clinically detectable when fluid accumulation exceeds approximately 1,500 milliliters, though smaller volumes may be detected by imaging.
Key Epidemiology
- Cirrhosis accounts for approximately 85% of all cases of ascites in Western countries
- Malignancy causes approximately 10% of ascites cases
- Heart failure accounts for approximately 3% of cases
- Other causes (tuberculosis, pancreatitis, nephrotic syndrome) comprise the remaining 2%
Classification by Volume (International Ascites Club)
| Grade | Description | Detection Method | Clinical Significance |
|---|---|---|---|
| Grade 1 (Mild) | Small volume, only detectable by ultrasound | Imaging only | Often incidental finding; may not require specific treatment |
| Grade 2 (Moderate) | Moderate symmetrical abdominal distension | Clinical examination | Symptomatic; responds to sodium restriction and diuretics |
| Grade 3 (Large) | Marked abdominal distension with tense ascites | Clinical examination | Often requires therapeutic paracentesis; may indicate refractory disease |
Classification by Onset and Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Days to weeks | Acute liver failure, acute pancreatitis, bowel perforation, acute Budd-Chiari syndrome | Often requires urgent investigation and intervention; may indicate surgical emergency |
| Subacute | Weeks to months | Newly decompensated cirrhosis, malignancy, tuberculous peritonitis | Requires thorough diagnostic workup; underlying cause may be reversible |
| Chronic | Greater than 3 months | Established cirrhosis, chronic heart failure, nephrotic syndrome | Focus on management and prevention of complications; assess for refractory ascites |
Classification by Treatment Response
Uncomplicated Ascites
Ascites that is not infected and does not meet criteria for refractory ascites. Responds to dietary sodium restriction (less than 2 grams per day) and diuretic therapy. Represents the majority of cases at initial presentation.
Refractory Ascites
Ascites that cannot be mobilized or that recurs early despite sodium restriction and maximum tolerated diuretic doses. Includes diuretic-resistant ascites (no response) and diuretic-intractable ascites (complications preclude effective diuretic use). Affects approximately 10% of patients with cirrhotic ascites.
Classification by Serum-Ascites Albumin Gradient
The Serum-Ascites Albumin Gradient (SAAG) is the single most useful test for categorizing ascites and has replaced the traditional transudate/exudate classification. It is calculated by subtracting the ascitic fluid albumin concentration from the serum albumin concentration.
| SAAG Value | Interpretation | Indicates | Common Causes |
|---|---|---|---|
| ≥ 1.1 g/dL (High) | Portal hypertension present | 97% accuracy for portal hypertension | Cirrhosis, alcoholic hepatitis, heart failure, Budd-Chiari syndrome, portal vein thrombosis |
| < 1.1 g/dL (Low) | Portal hypertension absent | Non-portal hypertensive cause | Peritoneal carcinomatosis, tuberculous peritonitis, pancreatitis, nephrotic syndrome, serositis |
Classification by Associated Features
| Pattern | Description | Suggests |
|---|---|---|
| Ascites with peripheral edema | Bilateral lower extremity swelling preceding or accompanying ascites | Cirrhosis, heart failure, nephrotic syndrome (hypoalbuminemic states) |
| Ascites with fever and abdominal pain | Signs of peritoneal inflammation | Spontaneous bacterial peritonitis, secondary peritonitis, tuberculous peritonitis |
| Ascites with weight loss and cachexia | Constitutional symptoms suggesting malignancy | Peritoneal carcinomatosis, hepatocellular carcinoma |
| Ascites with jaundice | Yellowing of skin and sclera | Decompensated cirrhosis, acute liver failure, biliary obstruction |
| Bloody ascites | Red blood cell count greater than 50,000 per microliter | Malignancy (most common), traumatic tap, hepatocellular carcinoma, tuberculosis |
| Chylous ascites | Milky appearance with triglycerides greater than 200 mg/dL | Lymphatic obstruction (malignancy, trauma, surgery), cirrhosis with thoracic duct obstruction |
Key Concept — The Dominant Cause: While the differential diagnosis of ascites is broad, cirrhosis accounts for approximately 85% of all cases in Western countries. However, approximately 5% of patients with cirrhosis have a second cause of ascites (such as peritoneal carcinomatosis or tuberculous peritonitis), emphasizing the importance of diagnostic paracentesis in all new-onset ascites regardless of known liver disease.
Impact on Quality of Life and Prognosis
Physical Impact
Abdominal distension causes early satiety, dyspnea (particularly when supine), reduced mobility, and difficulty with activities of daily living. Large-volume ascites may compress the inferior vena cava and reduce venous return.
Psychological Impact
Altered body image, social isolation, depression, and anxiety are common. Frequent hospital admissions and paracentesis procedures significantly impact quality of life.
Prognostic Significance
Development of ascites in cirrhosis marks transition from compensated to decompensated disease. Five-year survival drops from approximately 80% (compensated) to approximately 30% (decompensated with ascites).
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of ascites formation
Ascites formation results from a complex interplay of hemodynamic, hormonal, and local factors. Understanding these mechanisms is essential for rational treatment selection and predicting response to therapy. The pathophysiology differs significantly between portal hypertensive causes (primarily cirrhosis) and non-portal hypertensive causes (such as malignancy), with important implications for management.
Normal Peritoneal Fluid Homeostasis
| Component | Normal Function | Disruption in Disease |
|---|---|---|
| Peritoneal membrane | Semi-permeable barrier allowing passage of water and small solutes | Increased permeability in inflammation, malignancy, and infection |
| Splanchnic capillaries | Produce approximately 50 mL of serous fluid daily | Increased hydrostatic pressure in portal hypertension leads to transudation |
| Peritoneal lymphatics | Absorb peritoneal fluid; capacity approximately 800–1000 mL/day | Overwhelmed capacity or obstruction leads to fluid accumulation |
| Starling forces | Balance between hydrostatic and oncotic pressures maintains equilibrium | Imbalance favoring fluid extravasation causes ascites |
Mechanism of Ascites in Portal Hypertension (Cirrhosis)
The peripheral arterial vasodilation hypothesis is the most widely accepted explanation for ascites formation in cirrhosis. This represents a cascade of hemodynamic and neurohumoral changes that ultimately lead to sodium and water retention.
The Peripheral Arterial Vasodilation Hypothesis — Sequential Steps:
- Portal hypertension develops — Increased intrahepatic resistance and increased portal blood flow
- Splanchnic vasodilation occurs — Mediated by nitric oxide and other vasodilators produced in the splanchnic circulation
- Effective arterial blood volume decreases — Despite total blood volume being normal or increased, arterial underfilling occurs
- Compensatory mechanisms activate — Renin-angiotensin-aldosterone system, sympathetic nervous system, and antidiuretic hormone
- Sodium and water retention ensue — Kidneys retain sodium and water to compensate for perceived hypovolemia
- Ascites forms — Retained fluid accumulates in the peritoneal cavity due to portal hypertension and hypoalbuminemia
Key Vasoactive Mediators and Hormonal Systems
Nitric Oxide
Role: Primary mediator of splanchnic vasodilation
Source: Endothelial cells in splanchnic circulation
Effect: Reduces systemic vascular resistance, contributes to hyperdynamic circulation
Renin-Angiotensin-Aldosterone System
Role: Activated by arterial underfilling and sympathetic stimulation
Effect: Promotes sodium retention in proximal and distal tubules; aldosterone is primary target of spironolactone therapy
Antidiuretic Hormone (Vasopressin)
Role: Released in response to non-osmotic stimuli (arterial underfilling)
Effect: Causes water retention and dilutional hyponatremia; contributes to free water excess
Factors Contributing to Ascites in Cirrhosis
| Factor | Mechanism | Clinical Relevance |
|---|---|---|
| Portal hypertension | Increased hydrostatic pressure in splanchnic capillaries forces fluid into peritoneal cavity | SAAG ≥ 1.1 g/dL; correlates with portal pressure; threshold for ascites typically hepatic venous pressure gradient greater than 12 mmHg |
| Hypoalbuminemia | Reduced hepatic synthetic function decreases plasma oncotic pressure | Contributes to peripheral edema; correlates with disease severity; serum albumin less than 3.0 g/dL associated with higher risk |
| Splanchnic vasodilation | Reduces effective arterial blood volume, triggering sodium retention | Explains paradox of sodium retention despite total body sodium excess |
| Renal sodium retention | Activation of renin-angiotensin-aldosterone system and sympathetic nervous system | Target of diuretic therapy; natriuretic response predicts treatment success |
| Lymphatic overflow | Hepatic lymph production exceeds thoracic duct capacity | Hepatic lymph “weeps” from liver surface into peritoneal cavity |
Mechanisms of Ascites Without Portal Hypertension
Malignant Ascites (Peritoneal Carcinomatosis)
| Mechanism | Description | Clinical Implication |
|---|---|---|
| Increased peritoneal permeability | Tumor implants disrupt peritoneal membrane integrity | Protein-rich ascites (total protein typically greater than 2.5 g/dL) |
| Vascular endothelial growth factor production | Tumor cells secrete factors that increase vascular permeability | Explains rapid reaccumulation; may respond to targeted therapies |
| Lymphatic obstruction | Tumor blocks peritoneal lymphatic drainage | May cause chylous ascites if thoracic duct involved |
| Massive hepatic metastases | Can cause portal hypertension secondary to hepatic infiltration | May have high SAAG despite malignant cause |
Cardiac Ascites
Right-Sided Heart Failure
- Mechanism: Elevated central venous pressure transmitted to hepatic veins and sinusoids
- Effect: Increased hepatic venous pressure causes transudation similar to cirrhosis
- SAAG: High (≥ 1.1 g/dL) due to portal hypertension mechanism
Constrictive Pericarditis
- Mechanism: Impaired diastolic filling raises venous pressures
- Effect: Hepatic congestion and “cardiac cirrhosis” may develop
- Key feature: Ascites may be disproportionate to peripheral edema
Other Non-Portal Hypertensive Mechanisms
| Condition | Primary Mechanism | SAAG | Distinguishing Feature |
|---|---|---|---|
| Tuberculous peritonitis | Granulomatous inflammation increases peritoneal permeability | Low (< 1.1 g/dL) | High lymphocyte count; elevated adenosine deaminase |
| Nephrotic syndrome | Severe hypoalbuminemia reduces plasma oncotic pressure | Low (< 1.1 g/dL) | Heavy proteinuria; serum albumin often less than 2.0 g/dL |
| Pancreatic ascites | Pancreatic duct disruption leaks enzyme-rich fluid into peritoneum | Low (< 1.1 g/dL) | Very high amylase (often greater than 1000 U/L) |
| Chylous ascites | Disruption of lymphatic channels leaks triglyceride-rich lymph | Variable | Milky appearance; triglycerides greater than 200 mg/dL |
| Budd-Chiari syndrome | Hepatic venous outflow obstruction causes sinusoidal hypertension | High (≥ 1.1 g/dL) | High protein content despite high SAAG; caudate lobe hypertrophy |
Summary: How Different Conditions Cause Ascites
| Condition | Primary Mechanism | Treatment Implication |
|---|---|---|
| Cirrhosis | Portal hypertension + splanchnic vasodilation → arterial underfilling → sodium retention; lymphatic overflow | Sodium restriction and diuretics effective; target aldosterone with spironolactone |
| Heart failure | Elevated venous pressure → hepatic congestion → similar portal hypertension mechanism | Treat underlying cardiac disease; diuretics may help but address heart failure first |
| Peritoneal carcinomatosis | Increased peritoneal permeability + lymphatic obstruction; vascular endothelial growth factor-mediated leak | Diuretics usually ineffective; repeated paracentesis or indwelling catheter for palliation |
| Tuberculous peritonitis | Granulomatous inflammation increases peritoneal permeability | Antituberculous therapy curative; ascites resolves with treatment |
| Nephrotic syndrome | Severe hypoalbuminemia → decreased oncotic pressure; may have secondary hyperaldosteronism | Treat underlying renal disease; albumin infusion may help temporarily |
| Pancreatic ascites | Pancreatic duct disruption → direct leak of pancreatic secretions | Octreotide to reduce secretions; endoscopic or surgical intervention for duct disruption |
Often Overlooked Mechanism: Mixed Ascites
Approximately 5% of patients with cirrhosis have a second cause of ascites, most commonly peritoneal carcinomatosis or tuberculous peritonitis. This “mixed ascites” may present with atypical SAAG values or unexpected ascitic fluid findings. Always consider a second diagnosis when ascites behaves unexpectedly or does not respond to appropriate therapy. Diagnostic paracentesis should be performed in all patients with new-onset ascites, even those with known cirrhosis.
Mechanism of Ascites-Related Complications
| Complication | Mechanism | Clinical Significance |
|---|---|---|
| Spontaneous bacterial peritonitis | Bacterial translocation from gut; impaired ascitic fluid opsonic activity (low protein) | Occurs in ascites with low protein content (less than 1.0 g/dL); high mortality if untreated |
| Hepatorenal syndrome | Extreme splanchnic vasodilation → profound renal vasoconstriction → functional renal failure | Represents end-stage circulatory dysfunction; poor prognosis without liver transplantation |
| Umbilical hernia | Increased intra-abdominal pressure weakens umbilical ring | Risk of incarceration and rupture; surgical repair is high-risk in cirrhosis |
| Hepatic hydrothorax | Ascitic fluid crosses diaphragm through congenital defects (usually right-sided) | May cause dyspnea disproportionate to ascites volume; often refractory |
3. History Taking
A comprehensive approach to eliciting the ascites history
Red Flags — Require Urgent Evaluation
- Fever with abdominal pain — Spontaneous bacterial peritonitis or secondary peritonitis
- Altered mental status — Hepatic encephalopathy, sepsis, or hypoglycemia
- Hematemesis or melena — Variceal hemorrhage in portal hypertension
- Rapid onset over days — Acute liver failure, Budd-Chiari syndrome, or malignancy
- Severe abdominal pain with rigidity — Secondary peritonitis (bowel perforation)
- Decreasing urine output — Hepatorenal syndrome or acute kidney injury
- Hypotension or tachycardia — Sepsis, hemorrhage, or severe decompensation
- New-onset jaundice with ascites — Acute liver failure or acute-on-chronic liver failure
Systematic History: The “FLUID” Approach
Use the mnemonic “FLUID” to ensure comprehensive history taking for ascites:
- F — First noticed and Features: When did you first notice the swelling? How quickly did it develop? Is it painful? Have you noticed any change in size?
- L — Liver and Lifestyle: Do you have known liver disease? How much alcohol do you drink (quantify in standard drinks per day/week)? Any history of hepatitis or blood transfusions? Intravenous drug use?
- U — Underlying conditions and Urinary symptoms: Do you have heart failure, kidney disease, or cancer? Have you noticed changes in urine output? Any frothy urine (proteinuria)?
- I — Impact and Intake: How has this affected your breathing, appetite, and daily activities? What is your typical salt and fluid intake? Have you had weight changes?
- D — Drugs and Danger signs: What medications are you taking (especially NSAIDs, diuretics)? Have you had fevers, night sweats, weight loss, or abdominal pain?
Characterizing the Onset and Progression
| Onset Pattern | Typical Duration | Suggests | Key Questions |
|---|---|---|---|
| Sudden (hours to days) | Less than 1 week | Acute liver failure, Budd-Chiari syndrome, bowel perforation, acute pancreatitis | “Did the swelling appear suddenly? Were you previously well?” |
| Rapid (days to weeks) | 1–4 weeks | Malignancy, acute decompensation of cirrhosis, new-onset heart failure | “Over how many weeks did you notice the swelling increasing?” |
| Gradual (weeks to months) | Greater than 4 weeks | Cirrhosis, chronic heart failure, nephrotic syndrome, tuberculous peritonitis | “Has this been slowly building up over months?” |
| Fluctuating | Variable | Diuretic-responsive cirrhotic ascites, dietary sodium non-compliance | “Does the swelling come and go? What makes it better or worse?” |
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Cirrhosis (alcoholic) | History of heavy alcohol use, known liver disease, jaundice | “How much alcohol do you drink daily? For how many years? Have you ever been told you have liver problems?” |
| Cirrhosis (viral hepatitis) | Risk factors for hepatitis B or C, known viral infection | “Have you ever been diagnosed with hepatitis? Have you had blood transfusions before 1992, tattoos, or shared needles?” |
| Cirrhosis (non-alcoholic fatty liver disease) | Metabolic syndrome features, obesity, diabetes | “Do you have diabetes, high blood pressure, or high cholesterol? Have you been told you have a fatty liver?” |
| Heart failure | Dyspnea, orthopnea, paroxysmal nocturnal dyspnea, leg swelling preceding ascites | “Do you get short of breath lying flat? Do you wake up at night gasping for air? Did your legs swell before your abdomen?” |
| Malignancy | Weight loss, anorexia, known cancer history, rapid onset | “Have you had unintentional weight loss? Any history of cancer? Have you noticed any lumps or masses?” |
| Tuberculous peritonitis | Fever, night sweats, weight loss, endemic area exposure, immunosuppression | “Have you had fevers, drenching night sweats, or unexplained weight loss? Have you traveled to or lived in areas where tuberculosis is common?” |
| Nephrotic syndrome | Periorbital edema, frothy urine, known renal disease | “Have you noticed swelling around your eyes, especially in the morning? Is your urine frothy or bubbly?” |
| Budd-Chiari syndrome | Acute onset, right upper quadrant pain, hepatomegaly, hypercoagulable risk factors | “Did this come on very suddenly with abdominal pain? Do you have a history of blood clots? Are you taking oral contraceptives?” |
| Pancreatic ascites | History of pancreatitis, alcohol use, abdominal trauma | “Have you ever had pancreatitis? Any recent abdominal surgery or injury?” |
| Spontaneous bacterial peritonitis | Known cirrhotic ascites with new fever, abdominal pain, or encephalopathy | “Have you had a recent fever? Is your abdominal pain new or different? Have family members noticed you seem confused?” |
Associated Symptoms to Explore
Symptoms Suggesting Liver Disease
- Jaundice: Yellowing of skin and eyes (indicates hepatic dysfunction)
- Easy bruising or bleeding: Coagulopathy from decreased clotting factors
- Pruritus: Cholestatic liver disease
- Confusion or sleep disturbance: Hepatic encephalopathy
- Gynecomastia or testicular atrophy: Hormonal changes in cirrhosis
- Dark urine and pale stools: Biliary obstruction
Symptoms Suggesting Other Causes
- Dyspnea on exertion, orthopnea: Heart failure
- Periorbital edema (morning): Nephrotic syndrome
- Anorexia and early satiety: Malignancy or large-volume ascites
- Fever and night sweats: Infection (tuberculosis, spontaneous bacterial peritonitis)
- Chronic diarrhea: Protein-losing enteropathy
- Postprandial abdominal pain: Mesenteric ischemia (rare cause)
Medication and Substance History
Medications That May Cause or Worsen Ascites
- Nonsteroidal anti-inflammatory drugs (NSAIDs): Reduce renal prostaglandins, precipitate sodium retention and renal failure in cirrhosis
- Methotrexate: Hepatotoxicity with chronic use
- Amiodarone: Can cause cirrhosis with prolonged use
- Oral contraceptives: Risk factor for Budd-Chiari syndrome
- Calcium channel blockers: May cause peripheral edema (not true ascites)
- Herbal supplements: Various hepatotoxic compounds
Current Medications to Document
- Diuretics: Current doses, adherence, duration of use
- Beta-blockers: For portal hypertension (non-selective)
- Lactulose and rifaximin: For encephalopathy
- Prophylactic antibiotics: For spontaneous bacterial peritonitis prevention
- Anticoagulants: Relevant to Budd-Chiari, procedural risk
- Immunosuppressants: Risk for opportunistic infections
Social and Occupational History
| Factor | Relevance | Questions to Ask |
|---|---|---|
| Alcohol consumption | Leading cause of cirrhosis; quantify current and lifetime use | “How many drinks per day/week? What type? For how many years? Have you tried to quit?” |
| Intravenous drug use | Risk for hepatitis B and C | “Have you ever injected drugs? Shared needles?” |
| Sexual history | Hepatitis B transmission; HIV risk | “Have you had multiple sexual partners? Unprotected sex?” |
| Travel history | Endemic areas for hepatitis, tuberculosis, schistosomiasis | “Have you traveled to or lived in Africa, Asia, or South America?” |
| Occupational exposures | Vinyl chloride (hepatic angiosarcoma), healthcare workers (hepatitis) | “What is your occupation? Any exposure to chemicals or blood products?” |
| Dietary habits | Sodium intake affects ascites management; raw shellfish (Vibrio infection risk) | “Do you add salt to food? Eat processed foods? Do you eat raw oysters or shellfish?” |
| Living situation | Affects treatment compliance, home paracentesis feasibility | “Who do you live with? Can you attend regular medical appointments?” |
Family History
Conditions to Ask About
- Liver disease: Hemochromatosis, Wilson disease, alpha-1 antitrypsin deficiency
- Autoimmune diseases: Primary biliary cholangitis, autoimmune hepatitis
- Blood clotting disorders: Factor V Leiden, protein C/S deficiency (Budd-Chiari risk)
- Malignancy: Especially gastrointestinal and ovarian cancers
- Heart disease: Cardiomyopathy, congenital heart disease
Significance of Positive Family History
A family history of liver disease in a young patient without obvious cause should prompt investigation for hereditary conditions:
- Hemochromatosis: Iron studies, HFE gene testing
- Wilson disease: Ceruloplasmin, 24-hour urine copper
- Alpha-1 antitrypsin deficiency: Serum alpha-1 antitrypsin level
Functional and Quality of Life Assessment
Document the impact of ascites on daily functioning:
- Mobility: Can the patient walk without assistance? Climb stairs?
- Breathing: Dyspnea at rest or with minimal exertion? Orthopnea?
- Nutrition: Early satiety limiting oral intake? Recent weight changes?
- Sleep: Disrupted by dyspnea or frequent urination from diuretics?
- Work and social activities: Able to maintain employment? Social isolation?
This information helps guide treatment intensity and discussions about prognosis and goals of care.
4. Physical Examination
A systematic head-to-toe approach for ascites
Systematic Framework: Use the “General → Specific → Complications” approach for complete examination of patients presenting with ascites. Begin with general assessment, proceed to detailed abdominal examination, then systematically evaluate for signs of underlying etiology and complications.
General Inspection
- Body habitus: Cachexia (malignancy, advanced cirrhosis) versus obesity (metabolic syndrome, heart failure)
- Level of consciousness: Alertness, orientation, asterixis (hepatic encephalopathy)
- Respiratory pattern: Tachypnea, use of accessory muscles (large-volume ascites, hepatic hydrothorax)
- Skin color: Jaundice, pallor, bronze discoloration (hemochromatosis)
- Nutritional status: Muscle wasting, temporal wasting (chronic liver disease, malignancy)
- Position of comfort: Sitting upright (orthopnea from ascites or heart failure)
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever (greater than 38°C) or hypothermia | Fever suggests spontaneous bacterial peritonitis, secondary peritonitis, or other infection; hypothermia may occur in severe sepsis |
| Heart Rate | Tachycardia (greater than 100 beats per minute) | May indicate infection, hypovolemia (despite ascites), hyperdynamic circulation of cirrhosis, or anemia |
| Blood Pressure | Hypotension (systolic less than 90 mmHg) or low-normal pressures | Common in advanced cirrhosis due to vasodilation; acute drop suggests sepsis, hemorrhage, or hepatorenal syndrome |
| Respiratory Rate | Tachypnea (greater than 20 breaths per minute) | Large-volume ascites restricts diaphragmatic movement; consider hepatic hydrothorax or metabolic acidosis |
| Oxygen Saturation | Hypoxemia (less than 94% on room air) | Hepatopulmonary syndrome, hepatic hydrothorax, or concurrent pulmonary disease |
| Weight | Daily weight changes | Most reliable indicator of fluid balance; target weight loss of 0.5 kg/day (ascites alone) or 1 kg/day (ascites plus edema) |
Stigmata of Chronic Liver Disease
Systematically examine for signs that suggest cirrhosis as the underlying cause:
Hands and Arms
- Palmar erythema: Reddening of thenar and hypothenar eminences
- Dupuytren’s contracture: Associated with alcoholic liver disease
- Clubbing: May indicate hepatopulmonary syndrome
- Leukonychia: White nails (hypoalbuminemia)
- Terry’s nails: Proximal two-thirds white
- Asterixis: “Liver flap” (hepatic encephalopathy)
Head and Neck
- Jaundice: Best seen in sclera under natural light
- Fetor hepaticus: Sweet, musty breath odor
- Parotid enlargement: Alcoholic liver disease
- Spider angiomata: Upper body distribution (greater than 5 is significant)
- Elevated jugular venous pressure: Right heart failure, constrictive pericarditis
Trunk
- Spider angiomata: Check chest, shoulders, face
- Gynecomastia: Hormonal changes in cirrhosis
- Loss of body hair: Chest, axillary, pubic
- Caput medusae: Dilated periumbilical veins (portal hypertension)
- Testicular atrophy: In males with cirrhosis
Abdominal Examination
Inspection
- Abdominal distension: Generalized, symmetrical fullness; flanks may bulge when supine
- Umbilicus: Everted (tense ascites); herniation; Cullen’s sign (periumbilical bruising — rare, suggests hemorrhagic ascites)
- Skin changes: Striae, visible veins (direction of flow indicates portal versus caval obstruction), surgical scars
- Caput medusae: Dilated veins radiating from umbilicus (blood flow away from umbilicus)
- Hernias: Umbilical, inguinal (common in tense ascites due to increased intra-abdominal pressure)
Palpation
- Fluid thrill: Have assistant place edge of hand on midline abdomen; tap one flank and feel impulse on opposite side. Positive with large-volume ascites (greater than 1500 mL)
- Liver palpation: Hepatomegaly (congestion, malignancy, early cirrhosis) or small, hard liver (advanced cirrhosis); irregular edge suggests tumor nodules
- Splenomegaly: Palpable spleen suggests portal hypertension; use ballottement technique in ascites
- Tenderness: Diffuse tenderness suggests peritonitis; localized tenderness may indicate specific pathology
- Masses: Palpable tumor masses, Sister Mary Joseph nodule (periumbilical metastatic deposit)
Percussion
| Technique | How to Perform | Interpretation |
|---|---|---|
| Flank dullness | Percuss from midline laterally with patient supine | Dullness in flanks (fluid) with tympany centrally (bowel); absent flank dullness has 90% negative predictive value for ascites |
| Shifting dullness | Mark point where dullness begins; roll patient away from that side; re-percuss after 30 seconds | If dullness shifts toward dependent side by greater than 3 cm, ascites is likely present; most reliable bedside sign (sensitivity approximately 83%) |
| Puddle sign | Patient on hands and knees for 5 minutes; percuss from umbilicus toward flank | Can detect as little as 120 mL of ascites; rarely performed due to patient discomfort |
Clinical Pearl: Detecting Ascites
Physical examination can reliably detect ascites when fluid volume exceeds approximately 1500 mL. For smaller volumes, ultrasound is required. The absence of flank dullness makes ascites unlikely (sensitivity approximately 94%), while the presence of shifting dullness makes ascites likely (specificity approximately 90%). When both flank dullness and shifting dullness are present, the likelihood ratio for ascites is approximately 6.
Auscultation
- Bowel sounds: May be normal, hyperactive (early obstruction), or absent (peritonitis, ileus)
- Venous hum: Continuous hum heard over epigastrium or near umbilicus (portal hypertension with large collaterals); Cruveilhier-Baumgarten murmur if heard over a patent paraumbilical vein
- Arterial bruits: Hepatic bruit may suggest hepatocellular carcinoma or alcoholic hepatitis
- Friction rub: Rare; suggests hepatic or splenic infarction, tumor involvement of liver capsule
Cardiovascular Examination
| Finding | How to Assess | Clinical Significance |
|---|---|---|
| Jugular venous pressure | Assess at 45 degrees; measure height above sternal angle | Elevated (greater than 4 cm above sternal angle) suggests right heart failure, constrictive pericarditis, or fluid overload |
| Kussmaul’s sign | JVP rises paradoxically with inspiration | Suggests constrictive pericarditis or restrictive cardiomyopathy |
| Apex beat | Palpate in left lateral position | Displaced (cardiomegaly); heaving quality (pressure overload); difficult to locate in obesity or ascites |
| Heart sounds | Auscultate all areas | S3 gallop (heart failure); pericardial knock (constrictive pericarditis); murmurs (valvular disease) |
| Peripheral edema | Press over sacrum and lower extremities for pitting | Often accompanies ascites in cirrhosis, heart failure, and nephrotic syndrome |
Respiratory Examination
Key Findings
- Reduced breath sounds: At bases (pleural effusion, atelectasis from elevated diaphragm)
- Dullness to percussion: Usually right-sided if hepatic hydrothorax
- Decreased chest expansion: Large-volume ascites restricts diaphragm
Hepatic Hydrothorax
- Occurs in 5–10% of patients with cirrhotic ascites
- Right-sided in 85% of cases (diaphragmatic defects)
- May cause dyspnea disproportionate to ascites volume
- Can occur with minimal abdominal ascites
Lower Extremity Examination
- Peripheral edema: Pitting edema of ankles, legs, and sacrum; quantify as mild, moderate, or severe (or grade 1+ to 4+)
- Muscle wasting: Quadriceps atrophy (sarcopenia of chronic liver disease)
- Skin changes: Stasis dermatitis, hemosiderin deposition (chronic venous insufficiency)
- Deep vein thrombosis signs: Unilateral swelling, calf tenderness, warmth (hypercoagulability in malignancy, nephrotic syndrome)
Expected Findings by Etiology
| Condition | General Appearance | Abdominal Findings | Other Key Findings |
|---|---|---|---|
| Cirrhosis | Cachexia, jaundice, temporal wasting | Distended abdomen, hepatosplenomegaly (early) or small liver (late), caput medusae | Spider angiomata, palmar erythema, gynecomastia, asterixis, fetor hepaticus |
| Heart failure | Peripheral edema preceding ascites, orthopnea | Tender hepatomegaly (congestive hepatopathy), hepatojugular reflux positive | Elevated JVP, S3 gallop, bilateral pleural effusions, peripheral edema greater than ascites |
| Malignancy | Cachexia, lymphadenopathy, palpable masses | Hard, irregular hepatomegaly; Sister Mary Joseph nodule; palpable omental cake | Left supraclavicular node (Virchow’s node), pelvic mass on rectal examination |
| Tuberculous peritonitis | Fever, weight loss, night sweats | Doughy feel to abdomen; diffuse tenderness; hepatosplenomegaly | Lymphadenopathy, pulmonary signs if concurrent tuberculosis |
| Nephrotic syndrome | Periorbital edema (especially morning), anasarca | Ascites may be less prominent than peripheral edema | Frothy urine (if observed), edema in dependent areas |
| Budd-Chiari syndrome | Acute illness, right upper quadrant pain | Tender hepatomegaly (may be massive), caudate lobe hypertrophy (difficult to palpate) | Rapid onset; dilated abdominal wall veins with upward flow |
Important Teaching Point
Physical examination has limitations! While stigmata of chronic liver disease strongly suggest cirrhosis as the cause, their absence does not exclude it — approximately 30% of patients with compensated cirrhosis have no physical findings. Additionally, small-volume ascites (less than 1500 mL) cannot be reliably detected on examination. Ultrasound is more sensitive for detecting both ascites and hepatic parenchymal changes. Always proceed to diagnostic paracentesis in new-onset ascites regardless of physical findings.
Special Examination Maneuvers
| Maneuver | Technique | Interpretation |
|---|---|---|
| Hepatojugular reflux | Apply firm pressure over liver for 30–60 seconds while observing JVP | Sustained rise in JVP greater than 3 cm suggests right heart failure or constrictive pericarditis |
| Ballottement of liver/spleen | In the presence of ascites, use quick dipping motion to displace fluid and palpate organ | Allows assessment of liver and spleen size when ascites obscures standard palpation |
| Auscultatory percussion of liver span | Place stethoscope over liver; scratch lightly from periphery toward liver | Sound quality changes over liver edge; useful when ascites makes standard percussion difficult |
| Test for asterixis | Ask patient to extend arms, dorsiflex wrists, and spread fingers for 30 seconds | Flapping tremor indicates hepatic encephalopathy; also seen in uremia, carbon dioxide retention |
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
The differential diagnosis of ascites is best organized using the Serum-Ascites Albumin Gradient (SAAG), which categorizes causes based on the presence or absence of portal hypertension. This approach has 97% accuracy in distinguishing portal hypertensive from non-portal hypertensive causes and directly guides further investigation and management.
High SAAG Ascites (≥ 1.1 g/dL) — Portal Hypertension Present
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 85%) | Cirrhosis (all causes) | Stigmata of chronic liver disease, hepatosplenomegaly, history of liver disease or risk factors | Fever, abdominal pain (spontaneous bacterial peritonitis); altered mental status (encephalopathy); gastrointestinal bleeding |
| LESS COMMON (approximately 10%) | Cardiac ascites (heart failure, constrictive pericarditis) | Elevated jugular venous pressure, peripheral edema preceding ascites, S3 gallop, history of cardiac disease | Acute decompensation; new arrhythmia; chest pain |
| LESS COMMON | Alcoholic hepatitis (without established cirrhosis) | Recent heavy alcohol use, fever, tender hepatomegaly, leukocytosis, elevated bilirubin | Maddrey discriminant function greater than 32 indicates severe disease |
| UNCOMMON BUT SERIOUS (approximately 3%) | Budd-Chiari syndrome (hepatic vein thrombosis) | Acute onset, right upper quadrant pain, tender hepatomegaly, hypercoagulable risk factors | Fulminant presentation; acute liver failure; known myeloproliferative disorder |
| UNCOMMON BUT SERIOUS | Portal vein thrombosis | May be acute (abdominal pain, bloody diarrhea) or chronic (incidental finding, varices without cirrhosis) | Mesenteric ischemia signs; fever suggesting pylephlebitis |
| UNCOMMON BUT SERIOUS | Sinusoidal obstruction syndrome (veno-occlusive disease) | History of bone marrow transplant or chemotherapy, tender hepatomegaly, weight gain, jaundice | Occurs within 30 days of transplant; multi-organ failure |
| UNCOMMON | Massive hepatic metastases | Known primary malignancy, hard irregular hepatomegaly, weight loss | Rapid progression; liver failure |
| RARE | Myxedema (severe hypothyroidism) | Features of hypothyroidism, high protein ascites despite high SAAG | Myxedema coma |
Low SAAG Ascites (< 1.1 g/dL) — Portal Hypertension Absent
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| MOST COMMON IN THIS CATEGORY (approximately 50%) | Peritoneal carcinomatosis | Weight loss, anorexia, known malignancy (ovarian, gastric, colon, pancreatic), palpable masses | Rapid accumulation; bloody ascites; bowel obstruction |
| LESS COMMON (approximately 20%) | Tuberculous peritonitis | Fever, night sweats, weight loss, endemic area exposure, immunosuppression (HIV) | Concurrent pulmonary tuberculosis; disseminated disease |
| LESS COMMON | Pancreatic ascites | History of pancreatitis or pancreatic surgery, abdominal pain, very high ascitic amylase | Pancreatic necrosis; pseudocyst rupture |
| LESS COMMON | Nephrotic syndrome | Severe hypoalbuminemia, periorbital and peripheral edema, frothy urine, heavy proteinuria | Renal vein thrombosis; acute kidney injury |
| UNCOMMON | Serositis (systemic lupus erythematosus, rheumatoid arthritis) | Known autoimmune disease, polyserositis (pleural and pericardial effusions), arthritis | Lupus flare; concurrent nephritis |
| UNCOMMON | Bowel obstruction or infarction | Acute abdomen, absent bowel sounds, distension, peritoneal signs | Surgical emergency; strangulation; perforation |
| UNCOMMON | Biliary ascites (bile leak) | Recent biliary surgery or trauma, jaundice, very high ascitic bilirubin | Biliary peritonitis; sepsis |
| RARE | Peritoneal mesothelioma | Asbestos exposure history, abdominal pain, weight loss | Often presents late; poor prognosis |
Special Categories of Ascites
Step-by-Step Approach to Ascites Classification:
- Step 1: Perform diagnostic paracentesis — Calculate SAAG to determine if portal hypertension is present
- Step 2: If high SAAG — Evaluate for cirrhosis (most common), then cardiac causes, then vascular causes
- Step 3: If low SAAG — Evaluate for malignancy (most common in this category), infection, or other causes
- Step 4: Use ascitic fluid total protein to further refine diagnosis within SAAG categories
Chylous Ascites
| Cause Category | Examples | Mechanism | Key Features |
|---|---|---|---|
| Malignancy (most common in adults) | Lymphoma, metastatic carcinoma | Lymphatic obstruction by tumor | Weight loss, lymphadenopathy, progressive course |
| Cirrhosis | Advanced portal hypertension | Rupture of dilated lymphatics; thoracic duct obstruction | Known cirrhosis, other stigmata of liver disease |
| Surgical or traumatic | Post-abdominal surgery, lymph node dissection | Direct lymphatic injury | Recent surgery or trauma; often self-limiting |
| Infectious | Tuberculosis, filariasis | Lymphatic inflammation and obstruction | Endemic area; systemic symptoms |
| Congenital | Lymphatic malformations | Abnormal lymphatic development | Presents in childhood or young adulthood |
Bloody Ascites (Red Blood Cell Count Greater Than 50,000/μL)
Common Causes
- Malignancy: Most common cause of truly bloody ascites
- Hepatocellular carcinoma: Tumor rupture or invasion
- Traumatic paracentesis: Usually clears with continued drainage
Less Common Causes
- Tuberculous peritonitis: May cause bloody ascites
- Ruptured ectopic pregnancy: In women of childbearing age
- Abdominal trauma: Splenic or hepatic injury
Anatomical Approach to Ascites
Hepatic Causes
Cirrhosis (all causes)
Alcoholic hepatitis
Acute liver failure
Hepatocellular carcinoma
Massive hepatic metastases
Budd-Chiari syndrome
Cardiac Causes
Right-sided heart failure
Constrictive pericarditis
Tricuspid regurgitation
Restrictive cardiomyopathy
Cor pulmonale
Peritoneal Causes
Peritoneal carcinomatosis
Tuberculous peritonitis
Secondary bacterial peritonitis
Peritoneal mesothelioma
Serositis (lupus, rheumatoid)
Other Causes
Nephrotic syndrome
Pancreatic ascites
Biliary ascites
Chylous ascites
Myxedema
Ovarian disease (Meigs syndrome)
Etiologies of Cirrhosis (When Cirrhosis Is Identified)
| Cause | Approximate Frequency | Key Diagnostic Clues | Confirmatory Tests |
|---|---|---|---|
| Alcohol-related liver disease | 30–40% | History of heavy drinking (greater than 40 g/day women, greater than 60 g/day men), AST:ALT ratio greater than 2 | Clinical history; exclusion of other causes |
| Chronic hepatitis C | 25–30% | Risk factors (transfusions pre-1992, injection drug use), often asymptomatic until cirrhosis | Hepatitis C antibody, HCV RNA |
| Non-alcoholic steatohepatitis | 15–20% (increasing) | Metabolic syndrome, obesity, diabetes, often “cryptogenic” cirrhosis | Exclusion of other causes; may have steatosis on imaging |
| Chronic hepatitis B | 10–15% | Endemic area origin, vertical transmission, known chronic infection | Hepatitis B surface antigen, HBV DNA |
| Autoimmune hepatitis | 5% | Female predominance, other autoimmune diseases, elevated immunoglobulins | ANA, anti-smooth muscle antibody, elevated IgG |
| Primary biliary cholangitis | 2–3% | Middle-aged women, pruritus, fatigue, elevated alkaline phosphatase | Anti-mitochondrial antibody (AMA) |
| Hemochromatosis | 2–3% | Bronze skin, diabetes, arthropathy, family history | Elevated ferritin and transferrin saturation, HFE gene testing |
| Wilson disease | Rare (younger patients) | Age less than 40, neuropsychiatric symptoms, Kayser-Fleischer rings | Low ceruloplasmin, elevated 24-hour urine copper |
| Alpha-1 antitrypsin deficiency | Rare | Early-onset emphysema, family history, Northern European ancestry | Serum alpha-1 antitrypsin level, phenotype testing |
Drug-Induced Ascites and Liver Disease
| Drug or Drug Class | Mechanism | Characteristics | Management |
|---|---|---|---|
| Methotrexate | Direct hepatotoxicity with chronic use | Cirrhosis develops insidiously; cumulative dose-dependent | Discontinue; liver biopsy to assess fibrosis |
| Amiodarone | Phospholipidosis and steatohepatitis | Can cause cirrhosis; resembles alcoholic liver disease histologically | Discontinue; long half-life means slow resolution |
| Isoniazid | Idiosyncratic hepatotoxicity | Can cause acute liver failure; rarely progresses to cirrhosis | Discontinue immediately if hepatotoxicity develops |
| Oral contraceptives | Hypercoagulability causing Budd-Chiari syndrome | Acute presentation with hepatomegaly, ascites, abdominal pain | Discontinue; anticoagulation; possible intervention |
| Chemotherapy (various agents) | Sinusoidal obstruction syndrome; direct hepatotoxicity | Occurs after bone marrow transplant or certain chemotherapy regimens | Supportive care; defibrotide for sinusoidal obstruction syndrome |
| Nonsteroidal anti-inflammatory drugs | Do not cause ascites but worsen it in cirrhosis (reduce renal prostaglandins) | Sodium retention, renal impairment, diuretic resistance | Avoid in all patients with cirrhotic ascites |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| High SAAG + low ascitic protein (less than 2.5 g/dL) | Cirrhosis | Evaluate for cirrhosis etiology; high risk for spontaneous bacterial peritonitis |
| High SAAG + high ascitic protein (greater than 2.5 g/dL) | Cardiac ascites or Budd-Chiari syndrome | Echocardiogram; hepatic vein Doppler ultrasound |
| Low SAAG + high ascitic protein | Peritoneal carcinomatosis or tuberculous peritonitis | Ascitic fluid cytology; adenosine deaminase; CT imaging; consider laparoscopy |
| Milky (chylous) ascites | Lymphatic obstruction (malignancy most common) | Ascitic fluid triglycerides; CT abdomen for lymphadenopathy/mass |
| Bloody ascites + weight loss | Malignancy (especially hepatocellular carcinoma) | CT or MRI; tumor markers (AFP); ascitic fluid cytology |
| Ascites + fever + abdominal pain in known cirrhotic | Spontaneous bacterial peritonitis | Urgent paracentesis; start empiric antibiotics if polymorphonuclear cells greater than 250/μL |
| Ascites + elevated jugular venous pressure + peripheral edema | Cardiac ascites (heart failure or constrictive pericarditis) | Echocardiogram; BNP/NT-proBNP |
| Ascitic amylase greater than 1000 U/L | Pancreatic ascites | CT pancreas; MRCP; evaluate for pancreatic duct disruption |
| Ascites + periorbital edema + frothy urine | Nephrotic syndrome | Urinalysis (proteinuria); spot urine protein:creatinine ratio; serum albumin |
| Acute onset + tender hepatomegaly + hypercoagulable risk | Budd-Chiari syndrome | Hepatic vein Doppler; CT/MRI with venous phase; thrombophilia workup |
Don’t Forget: Mixed Ascites
Approximately 5% of patients with cirrhosis have a second cause of ascites. Consider this possibility when:
- Ascites does not respond to appropriate diuretic therapy
- Ascitic fluid analysis shows unexpected findings (very high protein, positive cytology, very high lymphocyte count)
- Patient has risk factors for a second condition (known malignancy, tuberculosis exposure)
- Clinical course is atypical for cirrhotic ascites
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
The cornerstone of ascites evaluation is diagnostic paracentesis with ascitic fluid analysis. This should be performed in all patients with new-onset ascites, all patients admitted to hospital with ascites, and any patient with ascites who develops clinical deterioration. Additional investigations are guided by the ascitic fluid results and clinical suspicion.
Diagnostic Paracentesis — The Essential First Step
Indications for Diagnostic Paracentesis
- All new-onset ascites — To determine etiology
- All hospital admissions with ascites — To exclude spontaneous bacterial peritonitis
- Clinical deterioration — Fever, abdominal pain, encephalopathy, renal function decline, gastrointestinal bleeding
- Before starting antibiotic therapy — To obtain culture before antibiotics whenever possible
Note: There are virtually no absolute contraindications. Coagulopathy and thrombocytopenia are common in cirrhosis but do not preclude paracentesis. Routine correction of coagulation parameters is not required.
Ascitic Fluid Analysis
Routine Tests (Order in All Cases)
| Test | Purpose | Key Values and Interpretation | Practical Points |
|---|---|---|---|
| Cell count and differential | Diagnose spontaneous bacterial peritonitis | Polymorphonuclear cells ≥ 250/μL = spontaneous bacterial peritonitis (even if culture negative) | Most important test for infection; results available within hours |
| Albumin | Calculate SAAG | SAAG = Serum albumin − Ascitic albumin; ≥ 1.1 g/dL indicates portal hypertension | Must draw serum albumin simultaneously; 97% accuracy for portal hypertension |
| Total protein | Further classify cause; assess spontaneous bacterial peritonitis risk | Less than 1.0 g/dL = high risk for spontaneous bacterial peritonitis; greater than 2.5 g/dL suggests cardiac or Budd-Chiari | Use with SAAG for more specific diagnosis |
| Culture (aerobic and anaerobic) | Identify causative organism | Positive in approximately 40% of spontaneous bacterial peritonitis cases | Inoculate at bedside into blood culture bottles (10 mL each); sensitivity increases 3-fold |
| Glucose | Distinguish spontaneous from secondary bacterial peritonitis | Less than 50 mg/dL suggests secondary peritonitis or tuberculosis | Bacteria and neutrophils consume glucose |
Additional Tests (Order Based on Clinical Suspicion)
| Test | When to Order | Key Values and Interpretation |
|---|---|---|
| Cytology | Suspected malignancy; low SAAG ascites | Sensitivity approximately 60–90% for peritoneal carcinomatosis; may require large volume (50–200 mL) |
| Adenosine deaminase (ADA) | Suspected tuberculous peritonitis | Greater than 40 U/L suggests tuberculosis (sensitivity approximately 90%); lower cutoff in cirrhosis |
| Amylase | Suspected pancreatic ascites or gut perforation | Greater than 1000 U/L suggests pancreatic source; elevated in gut perforation |
| Lactate dehydrogenase (LDH) | Distinguish spontaneous from secondary bacterial peritonitis | Ascitic LDH greater than serum upper limit suggests secondary peritonitis or malignancy |
| Bilirubin | Suspected biliary leak; dark brown ascites | Ascitic bilirubin greater than serum bilirubin indicates biliary source |
| Triglycerides | Milky (chylous) appearance | Greater than 200 mg/dL confirms chylous ascites; often greater than 1000 mg/dL |
| Gram stain | Suspected infection | Low sensitivity (approximately 10%); more useful in secondary peritonitis |
| Acid-fast bacilli smear and culture | Suspected tuberculosis | Very low sensitivity; culture takes weeks; peritoneal biopsy more definitive |
| Carcinoembryonic antigen (CEA) and alkaline phosphatase | Distinguish spontaneous from secondary bacterial peritonitis | CEA greater than 5 ng/mL or alkaline phosphatase greater than 240 U/L suggests gut perforation |
Interpreting SAAG with Total Protein
| SAAG | Total Protein | Most Likely Diagnoses |
|---|---|---|
| High (≥ 1.1 g/dL) | Low (less than 2.5 g/dL) | Cirrhosis (most common scenario) |
| High (≥ 1.1 g/dL) | High (greater than 2.5 g/dL) | Cardiac ascites, Budd-Chiari syndrome, early/mixed cirrhosis |
| Low (< 1.1 g/dL) | High (greater than 2.5 g/dL) | Peritoneal carcinomatosis, tuberculous peritonitis, pancreatic ascites |
| Low (< 1.1 g/dL) | Low (less than 2.5 g/dL) | Nephrotic syndrome (rare presentation as ascites) |
Blood Investigations
Baseline Tests for All Patients with Ascites
| Investigation | Purpose | Key Findings |
|---|---|---|
| Complete blood count | Assess for anemia, infection, hypersplenism | Thrombocytopenia (less than 150,000/μL) suggests portal hypertension; leukocytosis suggests infection |
| Comprehensive metabolic panel | Liver function, renal function, electrolytes | Elevated bilirubin, low albumin, elevated creatinine (hepatorenal syndrome risk); hyponatremia common |
| Coagulation studies (PT/INR) | Assess synthetic function | Prolonged in cirrhosis; used in prognostic scores (Child-Pugh, MELD) |
| Serum albumin | Calculate SAAG; assess synthetic function | Required simultaneously with ascitic albumin; low levels indicate advanced liver disease |
Tests to Determine Cirrhosis Etiology
First-Line Tests
- Hepatitis B serology: Surface antigen, core antibody, surface antibody
- Hepatitis C antibody: If positive, confirm with HCV RNA
- Iron studies: Ferritin, transferrin saturation (hemochromatosis screen)
- Autoimmune markers: ANA, anti-smooth muscle antibody, immunoglobulin levels
Second-Line Tests (If First-Line Negative)
- Ceruloplasmin: Wilson disease (especially if age less than 40)
- Alpha-1 antitrypsin level: Alpha-1 antitrypsin deficiency
- Anti-mitochondrial antibody: Primary biliary cholangitis
- HFE gene testing: If iron studies elevated
Imaging Studies
| Modality | Indications | What It Shows | Limitations |
|---|---|---|---|
| Abdominal ultrasound with Doppler | First-line imaging for all ascites; assess for portal hypertension | Ascites (detects as little as 100 mL), liver size and texture, splenomegaly, portal vein patency, hepatic vein flow | Operator-dependent; limited by body habitus and bowel gas |
| Computed tomography (CT) abdomen and pelvis | Suspected malignancy, unclear diagnosis, planning intervention | Masses, lymphadenopathy, peritoneal nodules, vascular abnormalities, pancreatic pathology | Radiation exposure; contrast contraindicated if renal impairment severe |
| Magnetic resonance imaging (MRI) with MRCP | Characterize liver lesions, biliary evaluation, Budd-Chiari syndrome | Detailed liver parenchyma, hepatocellular carcinoma characterization, biliary anatomy, vascular patency | Expensive; longer imaging time; contraindicated with some implants |
| Echocardiography | Suspected cardiac cause; elevated jugular venous pressure | Ejection fraction, valvular disease, pericardial disease, right heart function | May not detect constrictive pericarditis well; CT or MRI may be needed |
| Chest radiograph | Baseline in all; assess for pleural effusion | Pleural effusion (hepatic hydrothorax typically right-sided), cardiomegaly, pulmonary pathology | Limited sensitivity for small effusions |
Targeted Investigations by Suspected Etiology
If Suspecting Spontaneous Bacterial Peritonitis
Diagnostic Criteria
- Ascitic fluid polymorphonuclear cells ≥ 250/μL — Diagnostic, even with negative culture
- Positive ascitic fluid culture — Confirms diagnosis; guides antibiotic selection
- No evidence of intra-abdominal surgical source — Distinguishes from secondary peritonitis
Exclude Secondary Peritonitis If:
- Ascitic glucose less than 50 mg/dL
- Ascitic LDH greater than serum upper limit
- Ascitic total protein greater than 1 g/dL
- Multiple organisms on culture
- Poor response to antibiotics at 48 hours
If Suspecting Malignancy
Initial Workup
- Ascitic fluid cytology: Submit 50–200 mL for highest sensitivity
- CT chest, abdomen, and pelvis: Identify primary tumor, staging
- Tumor markers: CA-125 (ovarian), CEA (gastrointestinal), CA 19-9 (pancreatic), AFP (hepatocellular carcinoma)
If Initial Workup Negative
- Repeat cytology: Sensitivity increases with multiple samples
- Diagnostic laparoscopy with peritoneal biopsy: Gold standard for peritoneal carcinomatosis
- PET-CT: May identify occult primary
If Suspecting Tuberculous Peritonitis
Ascitic Fluid Tests
- Adenosine deaminase: Greater than 40 U/L (lower cutoff if cirrhosis present)
- Lymphocyte predominance: Greater than 70% lymphocytes
- Acid-fast bacilli smear and culture: Low sensitivity; culture takes 4–8 weeks
- Mycobacterial PCR: Variable sensitivity
Additional Tests
- Chest radiograph: Concurrent pulmonary tuberculosis in approximately 30%
- Tuberculin skin test or interferon-gamma release assay: Supports diagnosis but does not confirm peritoneal involvement
- Laparoscopy with peritoneal biopsy: Gold standard; shows characteristic “millet seed” nodules
If Suspecting Cardiac Cause
| Test | Purpose | Key Findings |
|---|---|---|
| Brain natriuretic peptide (BNP) or NT-proBNP | Screen for heart failure | Elevated (greater than 400 pg/mL for BNP) suggests cardiac cause; may be elevated in cirrhosis too |
| Transthoracic echocardiogram | Assess cardiac structure and function | Reduced ejection fraction, valvular disease, pericardial thickening, right heart dilation |
| Cardiac CT or MRI | Evaluate for constrictive pericarditis | Pericardial thickening (greater than 4 mm), calcification, septal bounce |
| Right heart catheterization | Confirm constrictive pericarditis | Elevated and equalized diastolic pressures; “square root” sign |
Prognostic Assessment in Cirrhosis
| Score | Components | Purpose |
|---|---|---|
| Child-Pugh Score | Bilirubin, albumin, INR, ascites, encephalopathy (each scored 1–3) | Class A (5–6), B (7–9), C (10–15); guides prognosis and surgical risk |
| MELD Score (Model for End-Stage Liver Disease) | Bilirubin, creatinine, INR, sodium (MELD-Na) | Predicts 90-day mortality; used for transplant allocation |
| MELD-Na Score | MELD plus serum sodium | Better predictor than MELD alone; used in transplant listing |
When Initial Workup Is Non-Diagnostic
If ascitic fluid analysis and initial imaging do not reveal a clear diagnosis:
- Repeat paracentesis: Cell counts and cytology may vary; consider larger volume for cytology
- Diagnostic laparoscopy: Gold standard for peritoneal disease; allows direct visualization and biopsy
- Empiric anti-tuberculosis therapy: May be considered in high-risk patients while awaiting definitive diagnosis, particularly in endemic areas
- Trial of diuretics: Response to diuretics suggests portal hypertensive cause even if SAAG is borderline
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Fever, abdominal pain, and/or altered mental status in patient with ascites | EMERGENT | Immediate paracentesis; start empiric antibiotics (cefotaxime or ceftriaxone) if polymorphonuclear cells ≥ 250/μL; do not wait for culture |
| Hematemesis or melena with ascites | EMERGENT | Resuscitation; urgent endoscopy; octreotide infusion; prophylactic antibiotics; ICU admission |
| Tense ascites with respiratory distress | EMERGENT | Therapeutic paracentesis (large-volume); provide albumin if removing greater than 5 liters |
| Rapidly progressive ascites over days with abdominal pain | URGENT | Diagnostic paracentesis; hepatic vein Doppler to exclude Budd-Chiari syndrome; CT if malignancy suspected |
| New-onset ascites with jaundice and coagulopathy | URGENT | Evaluate for acute liver failure versus acute-on-chronic liver failure; early hepatology and transplant consultation |
| Rising creatinine in patient with cirrhotic ascites | URGENT | Hold diuretics; volume challenge with albumin; rule out infection; consider hepatorenal syndrome |
| New-onset ascites, stable patient | ROUTINE | Diagnostic paracentesis; calculate SAAG; initiate workup based on results |
| Known cirrhotic with gradual increase in ascites | ROUTINE | Assess dietary compliance; adjust diuretics; consider paracentesis if symptomatic |
Step 2: Initial Assessment Algorithm
All Patients with New-Onset Ascites:
- Perform diagnostic paracentesis — Send cell count, albumin, total protein, culture
- Calculate SAAG — Serum albumin minus ascitic albumin
- Classify as high SAAG (≥ 1.1 g/dL) or low SAAG (< 1.1 g/dL)
- Order additional tests based on clinical suspicion
- Obtain abdominal ultrasound with Doppler
Step 3: Follow the SAAG-Based Pathway
Algorithm A: High SAAG Ascites (≥ 1.1 g/dL)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Stigmata of chronic liver disease + low ascitic protein (less than 2.5 g/dL) | Cirrhosis | Determine cirrhosis etiology; start sodium restriction and diuretics; screen for hepatocellular carcinoma |
| Elevated jugular venous pressure + peripheral edema + high ascitic protein (greater than 2.5 g/dL) | Cardiac ascites | Echocardiogram; BNP; treat underlying heart failure; diuretics may help |
| Acute onset + tender hepatomegaly + high ascitic protein + hypercoagulable risk | Budd-Chiari syndrome | Urgent hepatic vein Doppler; CT/MRI; anticoagulation; consider intervention (TIPS, thrombolysis) |
| Recent heavy alcohol use + fever + leukocytosis + AST:ALT greater than 2 | Alcoholic hepatitis | Calculate Maddrey discriminant function; consider corticosteroids if severe; alcohol cessation support |
| Polymorphonuclear cells ≥ 250/μL in ascitic fluid | Spontaneous bacterial peritonitis | Start empiric antibiotics immediately; do not wait for culture; repeat paracentesis at 48 hours |
Algorithm B: Low SAAG Ascites (< 1.1 g/dL)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Weight loss + known malignancy + high ascitic protein | Peritoneal carcinomatosis | Ascitic cytology; CT staging; tumor markers; palliative care referral |
| Fever + night sweats + endemic area exposure + lymphocyte-predominant ascites | Tuberculous peritonitis | Adenosine deaminase level; consider laparoscopy with peritoneal biopsy; start anti-tuberculosis therapy if high suspicion |
| History of pancreatitis + very high ascitic amylase (greater than 1000 U/L) | Pancreatic ascites | CT pancreas; MRCP; consider octreotide; surgical or endoscopic intervention for duct disruption |
| Periorbital edema + frothy urine + serum albumin less than 2.0 g/dL | Nephrotic syndrome | 24-hour urine protein; renal biopsy if indicated; treat underlying glomerular disease |
| Known autoimmune disease + polyserositis | Serositis (lupus, rheumatoid) | Autoimmune serologies; treat underlying disease; corticosteroids or immunosuppression |
Spontaneous Bacterial Peritonitis: Critical Decision Points
Spontaneous Bacterial Peritonitis Management Algorithm
- Diagnose: Ascitic fluid polymorphonuclear cells ≥ 250/μL (do not wait for culture)
- Treat immediately: Cefotaxime 2 g IV every 8 hours (or ceftriaxone 2 g IV daily) for 5 days
- Prevent hepatorenal syndrome: Albumin 1.5 g/kg on day 1 and 1 g/kg on day 3 (if creatinine greater than 1 mg/dL, BUN greater than 30 mg/dL, or bilirubin greater than 4 mg/dL)
- Assess response: Repeat paracentesis at 48 hours; polymorphonuclear cells should decrease by ≥ 25%
- If no response: Broaden antibiotics; consider secondary peritonitis (CT imaging)
- Secondary prophylaxis: Norfloxacin 400 mg daily or trimethoprim-sulfamethoxazole after recovery
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient on diuretics develops rising creatinine | Hold diuretics immediately; check for infection; give albumin challenge (1 g/kg) | If creatinine does not improve with volume, consider hepatorenal syndrome; nephrology consult |
| Ascites not responding to maximum diuretics | Confirm sodium restriction compliance (spot urine sodium should be greater than potassium); rule out spontaneous bacterial peritonitis | Consider refractory ascites; evaluate for TIPS or serial large-volume paracentesis; transplant evaluation |
| Paracentesis yields bloody fluid | Check if traumatic tap (usually clears); if persistently bloody, consider malignancy | Send cytology; check hematocrit of fluid; CT imaging if hepatocellular carcinoma or malignancy suspected |
| Paracentesis yields milky fluid | Send triglyceride level (chylous if greater than 200 mg/dL) | Evaluate for lymphatic obstruction (malignancy most common); CT for lymphadenopathy; dietary modification (medium-chain triglycerides) |
| Patient with cirrhotic ascites develops confusion | Perform paracentesis to rule out spontaneous bacterial peritonitis; check ammonia; assess for precipitants | Treat hepatic encephalopathy (lactulose, rifaximin); address underlying trigger (infection, bleeding, constipation) |
| Ascites recurs rapidly after paracentesis | Reassess sodium restriction compliance; optimize diuretics | If truly refractory, consider TIPS evaluation; indwelling peritoneal catheter for palliative cases |
| SAAG is borderline (around 1.1 g/dL) | Repeat paracentesis; consider mixed ascites (two causes) | Pursue workup for both portal hypertensive and non-portal hypertensive causes |
| Ascitic cytology negative but malignancy still suspected | Repeat cytology with larger volume (100–200 mL) | If still negative, diagnostic laparoscopy with peritoneal biopsy is gold standard |
Diuretic Management Algorithm for Cirrhotic Ascites
| Step | Action | Monitoring |
|---|---|---|
| 1. Sodium restriction | Limit to less than 2 grams (88 mmol) sodium per day | Dietary counseling; spot urine sodium to assess compliance |
| 2. Initial diuretic therapy | Spironolactone 100 mg + furosemide 40 mg daily (100:40 ratio) | Daily weight; goal weight loss 0.5 kg/day (ascites only) or 1 kg/day (ascites plus edema) |
| 3. Titrate diuretics | Increase every 3–5 days maintaining 100:40 ratio (maximum: spironolactone 400 mg, furosemide 160 mg) | Creatinine, potassium, sodium every 1–2 weeks during titration |
| 4. Assess response | If no response at maximum doses: confirm sodium restriction; rule out spontaneous bacterial peritonitis | Spot urine sodium greater than urine potassium indicates adequate natriuresis |
| 5. Refractory ascites | Consider serial large-volume paracentesis with albumin; TIPS evaluation; transplant referral | Monitor for hepatorenal syndrome, encephalopathy, nutritional decline |
Troubleshooting Refractory Ascites
Ask These Questions When Ascites Does Not Respond
- Is sodium restriction adequate? — Spot urine sodium should exceed urine potassium if compliant
- Is diuretic dose adequate? — Titrate to maximum tolerated doses before declaring refractory
- Is there unrecognized spontaneous bacterial peritonitis? — Repeat paracentesis
- Is the diagnosis correct? — Reconsider if low SAAG or atypical features
- Is there a second cause of ascites? — Mixed ascites in approximately 5% of cirrhotics
- Has hepatocellular carcinoma developed? — Screening ultrasound if not done recently
- Is portal vein thrombosis present? — Doppler ultrasound to assess patency
- Is the patient taking NSAIDs? — These cause diuretic resistance and should be stopped
When to Refer
Hepatology/Gastroenterology Referral
- All new diagnoses of cirrhosis
- Refractory ascites not responding to maximal medical therapy
- Consideration for TIPS procedure
- Liver transplant evaluation
- Recurrent spontaneous bacterial peritonitis
- Hepatocellular carcinoma
Other Specialty Referrals
- Cardiology: Cardiac ascites, constrictive pericarditis
- Oncology: Peritoneal carcinomatosis, malignant ascites
- Infectious disease: Tuberculous peritonitis
- Interventional radiology: TIPS, portal vein intervention
- Surgery: Secondary peritonitis, symptomatic umbilical hernia (high risk)
- Palliative care: Refractory malignant ascites, end-stage liver disease not transplant candidates
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
SAAG is the single most useful test: The Serum-Ascites Albumin Gradient has 97% accuracy in distinguishing portal hypertensive from non-portal hypertensive causes. Always calculate it in new-onset ascites.
Always do a diagnostic paracentesis: Perform paracentesis in all new-onset ascites, all hospital admissions with ascites, and any clinical deterioration. It is safe even with coagulopathy and thrombocytopenia — routine correction is not needed.
Spontaneous bacterial peritonitis can be subtle: Classic symptoms (fever, abdominal pain) are absent in up to one-third of cases. Always paracentesis if a cirrhotic patient deteriorates, even without obvious signs of infection.
Treat spontaneous bacterial peritonitis empirically: Start antibiotics immediately if ascitic polymorphonuclear cells ≥ 250/μL. Do not wait for culture results — mortality increases with delayed treatment.
Albumin prevents hepatorenal syndrome in spontaneous bacterial peritonitis: Administer albumin 1.5 g/kg on day 1 and 1 g/kg on day 3 for high-risk patients (creatinine greater than 1 mg/dL, BUN greater than 30 mg/dL, or bilirubin greater than 4 mg/dL).
Use the 100:40 ratio for diuretics: Spironolactone and furosemide at a 100:40 mg ratio (e.g., 100 mg:40 mg, 200 mg:80 mg) maintains potassium balance and maximizes natriuresis.
High SAAG plus high protein suggests cardiac or Budd-Chiari: Cirrhosis typically has low ascitic protein (less than 2.5 g/dL). If protein is high despite high SAAG, consider cardiac ascites or hepatic venous outflow obstruction.
Inoculate culture bottles at bedside: Placing 10 mL of ascitic fluid into blood culture bottles at the bedside increases culture sensitivity from approximately 40% to approximately 80%.
Critical Pitfalls to Avoid
Skipping paracentesis because of coagulopathy: There is no safe INR or platelet threshold. Bleeding complications are rare (less than 1%) even with significant coagulopathy. Do not transfuse products prophylactically.
Using only culture to diagnose spontaneous bacterial peritonitis: Cultures are negative in up to 60% of cases. Diagnosis is based on polymorphonuclear cells ≥ 250/μL — treat empirically regardless of culture result.
Prescribing NSAIDs to patients with cirrhotic ascites: NSAIDs reduce renal prostaglandins, causing sodium retention, diuretic resistance, and acute kidney injury. They are absolutely contraindicated.
Forgetting albumin replacement after large-volume paracentesis: Removing greater than 5 liters without albumin (6–8 g per liter removed) causes post-paracentesis circulatory dysfunction and increases mortality.
Assuming all ascites in a cirrhotic is from cirrhosis: Approximately 5% have a second cause (malignancy, tuberculosis). Always analyze ascitic fluid — do not assume the cause even in known cirrhotics.
Overlooking cardiac causes: Cardiac ascites (heart failure, constrictive pericarditis) is the second most common cause of high SAAG ascites. Look for elevated jugular venous pressure and peripheral edema preceding ascites.
Aggressive diuresis in hepatorenal syndrome: Hepatorenal syndrome is not a volume-overloaded state — it is a vasoconstrictive response to splanchnic vasodilation. Diuretics worsen renal function; stop them and give albumin.
Delaying transplant referral: Development of ascites indicates decompensated cirrhosis with significantly reduced survival. Refer for transplant evaluation early, even if ascites is well controlled initially.
Key Takeaways
- Cirrhosis accounts for approximately 85% of ascites cases in Western countries; always calculate SAAG to confirm portal hypertension is present.
- Diagnostic paracentesis is the cornerstone of ascites evaluation — perform it in all new-onset cases and hospital admissions, and never withhold it due to coagulopathy.
- Spontaneous bacterial peritonitis is diagnosed by ascitic polymorphonuclear cells ≥ 250/μL; start antibiotics immediately without waiting for culture.
- Use the combination of SAAG and ascitic total protein to narrow the differential: high SAAG + low protein = cirrhosis; high SAAG + high protein = cardiac or Budd-Chiari; low SAAG + high protein = malignancy or tuberculosis.
- First-line management of cirrhotic ascites is sodium restriction (less than 2 g/day) and dual diuretic therapy (spironolactone and furosemide in 100:40 ratio).
- Albumin administration is essential: give 6–8 g per liter removed during large-volume paracentesis (greater than 5 L) and during spontaneous bacterial peritonitis treatment in high-risk patients.
- Avoid NSAIDs in all patients with cirrhotic ascites — they cause diuretic resistance and precipitate renal failure.
- Rising creatinine in a patient with ascites requires immediate action: hold diuretics, rule out infection, and consider hepatorenal syndrome.
- Development of ascites marks the transition from compensated to decompensated cirrhosis — 5-year survival drops from approximately 80% to approximately 30%; early transplant referral is essential.
- Never forget “mixed ascites” — approximately 5% of cirrhotics have a second cause; investigate if ascites behaves atypically or does not respond to standard therapy.
Quick Reference Algorithm
Systematic Approach to Ascites:
- Assess urgency: Look for red flags (fever, pain, altered mental status, respiratory distress, gastrointestinal bleeding) — treat emergencies first
- Perform diagnostic paracentesis: Send cell count, albumin, total protein, and culture in all cases
- Calculate SAAG: Serum albumin minus ascitic albumin
- ≥ 1.1 g/dL = Portal hypertension (cirrhosis, cardiac, Budd-Chiari)
- < 1.1 g/dL = No portal hypertension (malignancy, tuberculosis, pancreatic, nephrotic)
- Exclude spontaneous bacterial peritonitis: If polymorphonuclear cells ≥ 250/μL, start empiric antibiotics immediately
- Obtain imaging: Abdominal ultrasound with Doppler for all; CT if malignancy or vascular cause suspected
- Initiate treatment: Sodium restriction plus diuretics for cirrhotic ascites; address underlying cause for non-cirrhotic ascites
- Monitor response: Daily weights, renal function, electrolytes; target 0.5–1 kg/day weight loss
- Consider transplant: Refer all patients with cirrhotic ascites for transplant evaluation
High-Yield Facts for Clinical Practice
| Topic | Key Fact |
|---|---|
| SAAG threshold | ≥ 1.1 g/dL indicates portal hypertension with 97% accuracy |
| Spontaneous bacterial peritonitis diagnosis | Ascitic polymorphonuclear cells ≥ 250/μL (treat even if culture negative) |
| Spontaneous bacterial peritonitis prophylaxis indication | Ascitic protein less than 1.0 g/dL or prior spontaneous bacterial peritonitis episode |
| Diuretic ratio | Spironolactone:furosemide = 100:40 mg (maintains potassium balance) |
| Maximum diuretic doses | Spironolactone 400 mg/day; furosemide 160 mg/day |
| Weight loss targets | 0.5 kg/day (ascites only); 1 kg/day (ascites plus peripheral edema) |
| Albumin for large-volume paracentesis | 6–8 g albumin per liter removed if greater than 5 L drained |
| Chylous ascites definition | Ascitic triglycerides greater than 200 mg/dL (often greater than 1000 mg/dL) |
| Tuberculous peritonitis marker | Adenosine deaminase greater than 40 U/L (lower cutoff in cirrhosis) |
| Survival impact | Development of ascites reduces 5-year survival from approximately 80% to approximately 30% |